Vertex Pharmaceuticals Incorporated logo

Vertex Pharmaceuticals Incorporated (VRTX)

$492.26

Vertex Pharmaceuticals Incorporated (VRTX) Share Price Forecast
Currently 38 wall-street analysts regularly analyze the financials of Vertex Pharmaceuticals Incorporated on a frequent basis to provide recommendations along with target share price. 38 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Incorporated (VRTX) have a share price target of $481.41. This median of share price forecast represents a -2.2% downside from the latest price of $492.26 as on 26.07.24.

Vertex Pharmaceuticals Incorporated (VRTX) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Vertex Pharmaceuticals Incorporated (VRTX) share price will touch around $481.41 in next 12-months.
Vertex Pharmaceuticals Incorporated (VRTX) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Vertex Pharmaceuticals Incorporated's share price and its median forecast price. As on 26.07.24, the difference is -2.11%

Vertex Pharmaceuticals Incorporated (VRTX): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Vertex Pharmaceuticals Incorporated (VRTX) Share Price : Analyst Recommendation
Based on 38 analysts tracking and researching Vertex Pharmaceuticals Incorporated (VRTX) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
16
16
16
Outperform
10
10
10
Hold
8
10
10
Underperform
1
1
1
Sell
1
1
1
Vertex Pharmaceuticals Incorporated (VRTX) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Vertex Pharmaceuticals Incorporated (VRTX) is $481.41, offered by 38 analysts offering 12-month price forecasts.

Vertex Pharmaceuticals Incorporated (VRTX) has a maximum of -0.02 downside potential, based on 38 analysts offering 12-month price forecasts.

Based on 38 analysts tracking and researching Vertex Pharmaceuticals Incorporated (VRTX), 68.42% have a buy recommendation. Remaining 31.58% have either sell or hold recommendations.

The latest share price of Vertex Pharmaceuticals Incorporated (VRTX) is $492.26 as of 26/07/2024.

26 of total 38 analysts offering stock ratings for Vertex Pharmaceuticals Incorporated VRTX have recommended buy rating.